Great progress has been made in cancer treatment. Prostate cancer screening is a process that involves the detection of cancerous growth before its symptoms become visible despite the slow growth of the cancerous cells which may grow or not.
There are two tests commonly used to screen the prostatic cancerous growth which is the Digital-Rectal exam where the doctor inserts a finger in gloves which has been lubricated into the rectum to feel and approximate the prostate gland and feel for any abnormalities such as the lumps.
The prostate specific antigen test which measures the quantity of the antigens specific to prostate and are made by the prostate in the blood. The PSA levels in men are considered to be higher in men with cancerous growth present in them. It may also increased by other factors affecting the glands. Certain medical procedures and medications as well as age and race may also affect the PSA levels.
After the PSA based screening tests a patient may test positive for asymptomatic cancer which may or may not develop over time. This entirely depends on the patient.
The main purpose of the screening is to reduce the deaths of the patients as well as the metastasization of the disease. Prostate tumor patients have three possible occurrences. Some of them may die despite the early detection and adequate treatment, some of them will survive even with no prior screening procedures and some of them survive with the early detection and proper adequate treatment however, there's a lesser chance of survival in this case.
The PSA test could provide a fifty-fifty situation on the results they are not certain and may be true or false while in some cases cause harm on the patient. The false results may be caused by negative psychological situations that affect the patients such as continuous worry on the cancer situation. Biopsy is a form of treatment that the patients may undergo. They are likely to be exposed to urinary difficulties, fever, pain, bleeding and infections are advised to consult medical assistance and follow up if this happens. The long-term effect of the PSA screening is still uncertain. Studies carried out may have proven there's a low chance of the reduction of the cancer's mortality rate.
The screen detection and the treatment process of the tumor have caused most if not all effects experienced by most patients, they are too persistent and unprecedented thus may cause an early death.
Most men will experience effects more than the benefits brought about by the screening as well as the treatment process. There's a chance of over treating or over diagnosis of cancerous growth this means that the men will experience adverse effects due to the diagnosis and treatment of the disease which would have probably remained asymptomatic their entire lives.
Doctors and patients need to assess the balance between the advantages and disadvantages of early detection through the screen tests and early treatment. They are meant to determine if it provides chances of preventing death which are low or if it aggregates the prostate cancer through the persistent harm caused by the treatment procedures.
There are two tests commonly used to screen the prostatic cancerous growth which is the Digital-Rectal exam where the doctor inserts a finger in gloves which has been lubricated into the rectum to feel and approximate the prostate gland and feel for any abnormalities such as the lumps.
The prostate specific antigen test which measures the quantity of the antigens specific to prostate and are made by the prostate in the blood. The PSA levels in men are considered to be higher in men with cancerous growth present in them. It may also increased by other factors affecting the glands. Certain medical procedures and medications as well as age and race may also affect the PSA levels.
After the PSA based screening tests a patient may test positive for asymptomatic cancer which may or may not develop over time. This entirely depends on the patient.
The main purpose of the screening is to reduce the deaths of the patients as well as the metastasization of the disease. Prostate tumor patients have three possible occurrences. Some of them may die despite the early detection and adequate treatment, some of them will survive even with no prior screening procedures and some of them survive with the early detection and proper adequate treatment however, there's a lesser chance of survival in this case.
The PSA test could provide a fifty-fifty situation on the results they are not certain and may be true or false while in some cases cause harm on the patient. The false results may be caused by negative psychological situations that affect the patients such as continuous worry on the cancer situation. Biopsy is a form of treatment that the patients may undergo. They are likely to be exposed to urinary difficulties, fever, pain, bleeding and infections are advised to consult medical assistance and follow up if this happens. The long-term effect of the PSA screening is still uncertain. Studies carried out may have proven there's a low chance of the reduction of the cancer's mortality rate.
The screen detection and the treatment process of the tumor have caused most if not all effects experienced by most patients, they are too persistent and unprecedented thus may cause an early death.
Most men will experience effects more than the benefits brought about by the screening as well as the treatment process. There's a chance of over treating or over diagnosis of cancerous growth this means that the men will experience adverse effects due to the diagnosis and treatment of the disease which would have probably remained asymptomatic their entire lives.
Doctors and patients need to assess the balance between the advantages and disadvantages of early detection through the screen tests and early treatment. They are meant to determine if it provides chances of preventing death which are low or if it aggregates the prostate cancer through the persistent harm caused by the treatment procedures.
About the Author:
You can visit smart-surgery.com for more helpful information about Answers On Prostate Cancer Screening.
No comments:
Post a Comment